Abstract

摘要： 生活质量(quality of life,QoL)是指个人在生理、心理和社会功能方面对其生活环境的主观感受,在临床工作及研究中,QoL作为评价治疗效果的目标之一,已经越来越受到重视。注意缺陷多动障碍(attention-deficit hyperactivity disorder,ADHD)是儿童期最常见的一种心理行为疾病,了解QoL对于更全面评估ADHD具有重要意义。本文介绍了ADHD患者的QoL特点及影响因素,以及各种治疗方法,尤其是药物对QoL的影响,并提出了未来ADHD QoL的研究方向。

关键词: 注意缺陷多动障碍, 生活质量, 兴奋剂, 非兴奋剂, 儿童

CLC Number:

R749.94

顾静雯,吴胜虎,徐通. 注意缺陷多动障碍对患者生活质量的影响[J]. 中国儿童保健杂志, 2013, 21(9): 956-959.

References

[1] Coghill D.The impact of medications on quality of life in Attention-Deficit Hyperactivity Disorder[J].CNS Drug,2010,24(10):843-866.
[2] Coghill D,Danckaerts M,Sonuga-Barke E,et al.Practitioner review: quality of life in child mental health-conceptual challenges and practical choices[J].J Child Psychol Psychiatry,2009,50(5):544-561.
[3] Moss MS,Hoffman CJ,Mossey J,et al.Changes over 4 years in health,quality of life,mental health,and valuation of life[J].J Aging Health,2007,19(6):1025-1044.
[4] Danckaerts M,Sonuga-Barke EJ,Banaschewski T,et al.The quality of life of children with attention deficit/hyperactivity disorder: a systematic review[J].Eur Child Adolesc Psychiatry,2010,19(2):83-105.
[5] Escobar R,Schacht A,Peter M.W,et al.Quality of life and attention-deficit/hyperactivity disorder core symptoms[J].Journal of Clinical Psychopharmacology,2010,30(2):145-151.
[6] Leo B.Improvement in global psychopathology increases quality of life during treatment of ADHD with atomoxetine or stimulants[J/OL].Psychiatric Quarterly 2011[2011-3-25].
[7] Flapper BC,Schoemaker MM.Effect of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD[J].Develop Med Child Neurol,2008,50(4):294-299.
[8] Manos M,Frazier TW,Landgraf JM,et al.HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system[J].Curr Med Res Opin,2009,25(12):3001-10.
[9] Rothenberger A,Becker A.An observational study of once-daily modified-release methylphenidate in ADHD:quality of life,satisfaction with treatment and adherence[J].Eur Child Adolesc psychiatry,2011,20(2):257-265.
[10] Kordon A,Stollhoff K.Exploring the impact of once-daily OROS(R) methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPH[J].Posgrod Med,2011,123(5):27-38.
[11] Bukstein OG,Arnold LE,Landgraf JM,et al.Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life andmedication satisfaction for children with attention-deficit/hyperactivity disorder?[J].Child Adolesc Psychiatry Ment Health,2009,3(1):39.
[12] Cheng JY,Chen RY,Ko JS,et al.Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents: meta-analysis and metaregression analysis[J].Psychopharmacology (Berl),2007,194(2):197-209.
[13] Prasad S,Harpin V,Poole L,et al.A multi-centre,randomised,open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD)[J].Curr Med Res Opin,2007,23(2):379-394.
[14] Escobar R,Montoya A,Polavieja P,et al.Evaluation of patients' and parents' quality of life in a randomized placebo-controlled atomoxetine study in attention-deficit/hyperactivity disorder[J].J Child Adolesc Psychopharmacol,2009,19(3):253-263.
[15] Saylor K,Williams DW,Schuh KJ,et al.Effects of atomoxetine on self-reported high-risk behaviors and health-related quality of life in adolescents with ADHD[J].Curr Med Res Opin,2010,26(9):2087-2095.
[16] Peter MW,Schacht A,Dittmann RW,et al.Effect of atomoxetine on quality of life and family burden: results from a randomized,placebo-controlled,double-blind studyin children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder[J].Qual Life Res,2011,20(5):691-702.

注意缺陷多动障碍对患者生活质量的影响

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	TANG Yajun, LIU Xiumei. Research progress on dietary nutrition and intestinal flora in children with tic disorder [J]. Chinese Journal of Child Health Care, 2024, 32(11): 1232-1235.
[2]	LIN Duan, LIU Xiumei. Research progress on the role of histamine in the pathogenesis of tic disorder [J]. Chinese Journal of Child Health Care, 2024, 32(11): 1236-1240.
[3]	CHEN Yanhui, KE Zhongling. Psycho-behavioral intervention for tic disorder based on neurophysioloy [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1045-1049.
[4]	LU Yanting, CHEN Liangliang, LIU Xiumei. Mediating role of premonitory urge on the impact of comorbidity with attention-deficit/hyperactivity disorder on tic severity in children with tic disorder [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1050-1054.
[5]	GAN Kaiyan, HUANG Anqi, ZHANG Ziyi, GUAN Luyang, WANG Fei, KE Xiaoyan. Prospective study of the stability of early diagnosis of autism spectrum disorder with positive screening results of Modified Checklist for Autism in Toddlers [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1076-1079.
[6]	YANG Fan, LI Qinghong, LI Yiming, YANG Shunbo, LI Wei, LYU Zhihai. Status of screen use and its association with core symptoms in children with autism spectrum disorder [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1080-1084.
[7]	ZHANG Panpan, ZHAO Tingting, XIAO Xuwu. Correlation between intestinal flora and tic disorder [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1091-1096.
[8]	QIU Jiaqi , ZHONG Xia, ZOU Shipu. Role of dopamine and its receptors in tic disorder in children [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1097-1100.
[9]	XU Ying, SHI Haishui, ZHANG Huifeng, TIAN Xiaoyu. Role of GABAergic system in the pathogenesis and treatment of Tourette syndrome in children [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1101-1105.
[10]	LI Zhonggui, WANG Haifei, HUANG Meilin, JING Jin. Cognitive impairments of children with tic disorder [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1106-1110.
[11]	LI Shuai, HUANG Qijun, XIA Yu, LIU Zhenhuan. Meta-analysis of the correlation of prenatal, perinatal and environmental risk factors with childhood autism [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1122-1127.
[12]	JIANG Yanlin, WANG Junhong, LI Jialin, ZHAI Rui, JIANG Xiulei. Construction of a risk prediction scoring system for tic disorders in Chinese children based on Meta-analysis and external validation [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1128-1134.
[13]	ZHANG Liwen, QIN Xing, LI Juan, SONG Zixia, WU Weiwei. Efficacy of EEG biofeedback combined with methylphenidate hydrochloride in the treatment of childhood attention deficit hyperactivity disorder and its effect on cerebral blood flow and serum cortisol level [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1135-1139.
[14]	DONG Chao, ZHANG Linlin, ZHONG Yunyu, LIU Yun, LIU Juan, WANG Peng, WANG Yufeng, YANG Binrang, WU Zhaomin, LI Ying. Multidimensional executive function deficits in children with attention deficit hyperactivity disorder assessed by Cambridge Neuropsychological Test Automated Battery [J]. Chinese Journal of Child Health Care, 2024, 32(10): 1149-1154.
[15]	WANG Yu, MA Xiaoping, YAO Rui, DU Tianju, LI Hua, LIU Li. Genetic etiology analysis of children with developmental delay and intellectual disabilities in Ningxia region [J]. Chinese Journal of Child Health Care, 2024, 32(9): 1008-1013.